Cipla is not a specific type of generic medicine itself, but it is one of the world's largest and most highly respected manufacturers of generic pharmaceutical products. A generic medicine is a drug that contains the exact same active chemical ingredient as a branded medication and is engineered to be identical in terms of dosage, safety, strength, quality, and intended use, but is sold at a significantly lower price once the original patent expires. Cipla's foundational corporate mission has long been centered on pioneering the mass production of these affordable generic alternatives, making life-saving treatments accessible to developing nations and price-conscious healthcare systems globally. The company gained extraordinary international fame in the early two thousands for successfully reverse-engineering complex antiretroviral therapies for HIV/AIDS and offering them to African countries at a fraction of the cost charged by Western multinational patent holders. Today, Cipla produces hundreds of different generic formulations across respiratory, cardiovascular, and oncology fields, cementing its legacy as a titan of global generic manufacturing.